405 related articles for article (PubMed ID: 35011468)
41. Antioxidant and anti-inflammatory properties of curcumin.
Menon VP; Sudheer AR
Adv Exp Med Biol; 2007; 595():105-25. PubMed ID: 17569207
[TBL] [Abstract][Full Text] [Related]
42. The Functional Roles of Curcumin on Astrocytes in Neurodegenerative Diseases.
Mohammadi A; Hosseinzadeh Colagar A; Khorshidian A; Amini SM
Neuroimmunomodulation; 2022; 29(1):4-14. PubMed ID: 34496365
[TBL] [Abstract][Full Text] [Related]
43. Experimental and clinical reports on anti-inflammatory, antioxidant, and immunomodulatory effects of Curcuma longa and curcumin, an updated and comprehensive review.
Memarzia A; Khazdair MR; Behrouz S; Gholamnezhad Z; Jafarnezhad M; Saadat S; Boskabady MH
Biofactors; 2021 May; 47(3):311-350. PubMed ID: 33606322
[TBL] [Abstract][Full Text] [Related]
44. Curcumin and its formulations: potential anti-cancer agents.
Ji JL; Huang XF; Zhu HL
Anticancer Agents Med Chem; 2012 Mar; 12(3):210-8. PubMed ID: 22044005
[TBL] [Abstract][Full Text] [Related]
45. A Comprehensive Review on the Benefits and Problems of Curcumin with Respect to Human Health.
Liu S; Liu J; He L; Liu L; Cheng B; Zhou F; Cao D; He Y
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889273
[TBL] [Abstract][Full Text] [Related]
46. Ameliorating potential of curcumin and its analogue in central nervous system disorders and related conditions: A review of molecular pathways.
Joshi P; Bisht A; Joshi S; Semwal D; Nema NK; Dwivedi J; Sharma S
Phytother Res; 2022 Aug; 36(8):3143-3180. PubMed ID: 35790042
[TBL] [Abstract][Full Text] [Related]
47. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review.
Soleimani V; Sahebkar A; Hosseinzadeh H
Phytother Res; 2018 Jun; 32(6):985-995. PubMed ID: 29480523
[TBL] [Abstract][Full Text] [Related]
48. Curcumin: New Insights into an Ancient Ingredient against Cancer.
Willenbacher E; Khan SZ; Mujica SCA; Trapani D; Hussain S; Wolf D; Willenbacher W; Spizzo G; Seeber A
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013694
[TBL] [Abstract][Full Text] [Related]
49. Advances in clinical study of curcumin.
Yang C; Su X; Liu A; Zhang L; Yu A; Xi Y; Zhai G
Curr Pharm Des; 2013; 19(11):1966-73. PubMed ID: 23116307
[TBL] [Abstract][Full Text] [Related]
50. Multitargeting by turmeric, the golden spice: From kitchen to clinic.
Gupta SC; Sung B; Kim JH; Prasad S; Li S; Aggarwal BB
Mol Nutr Food Res; 2013 Sep; 57(9):1510-28. PubMed ID: 22887802
[TBL] [Abstract][Full Text] [Related]
51. Antidotal or protective effects of Curcuma longa (turmeric) and its active ingredient, curcumin, against natural and chemical toxicities: A review.
Hosseini A; Hosseinzadeh H
Biomed Pharmacother; 2018 Mar; 99():411-421. PubMed ID: 29367110
[TBL] [Abstract][Full Text] [Related]
52. Correlations between morphological changes induced by curcumin and its biological activities.
Stoica L; Stoica BA; Olinici D; Onofrei P; Botez EA; Cotrutz CE
Rom J Morphol Embryol; 2018; 59(1):65-69. PubMed ID: 29940613
[TBL] [Abstract][Full Text] [Related]
53. Curcumin and Melanoma: From Chemistry to Medicine.
Nabavi SM; Russo GL; Tedesco I; Daglia M; Orhan IE; Nabavi SF; Bishayee A; Nagulapalli Venkata KC; Abdollahi M; Hajheydari Z
Nutr Cancer; 2018; 70(2):164-175. PubMed ID: 29300102
[TBL] [Abstract][Full Text] [Related]
54. Curcumin: a potential neuroprotective agent in Parkinson's disease.
Mythri RB; Bharath MM
Curr Pharm Des; 2012; 18(1):91-9. PubMed ID: 22211691
[TBL] [Abstract][Full Text] [Related]
55. Cellular and Molecular Mechanisms of Curcumin in Thyroid Gland Disorders.
Shakeri F; Bibak B; Safdari MR; Keshavarzi Z; Jamialahmadi T; Sathyapalan T; Sahebkar A
Curr Med Chem; 2022; 29(16):2878-2890. PubMed ID: 35142266
[TBL] [Abstract][Full Text] [Related]
56. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets.
Aggarwal BB; Sung B
Trends Pharmacol Sci; 2009 Feb; 30(2):85-94. PubMed ID: 19110321
[TBL] [Abstract][Full Text] [Related]
57. Curcumin Therapeutic Modulation of the Wnt Signaling Pathway.
Ashrafizadeh M; Ahmadi Z; Mohamamdinejad R; Yaribeygi H; Serban MC; Orafai HM; Sahebkar A
Curr Pharm Biotechnol; 2020; 21(11):1006-1015. PubMed ID: 32133961
[TBL] [Abstract][Full Text] [Related]
58. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.
Naksuriya O; Okonogi S; Schiffelers RM; Hennink WE
Biomaterials; 2014 Mar; 35(10):3365-83. PubMed ID: 24439402
[TBL] [Abstract][Full Text] [Related]
59. Heterocyclic Curcumin Derivatives of Pharmacological Interest: Recent Progress.
Martinez-Cifuentes M; Weiss-Lopez B; Santos LS; Araya-Maturana R
Curr Top Med Chem; 2015; 15(17):1663-72. PubMed ID: 25915614
[TBL] [Abstract][Full Text] [Related]
60. Curcumin, Cardiometabolic Health and Dementia.
Kim Y; Clifton P
Int J Environ Res Public Health; 2018 Sep; 15(10):. PubMed ID: 30250013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
